Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Rebus Holdings, Inc.
No Price
Closing Price OTC 28.04.2026:
0,0001 USD
28.04.2026 20:00
Current Prices from Rebus Holdings, Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
RBSH
USD
28.04.2026 20:00
0,0001 USD
0,00 USD
Company Profile for Rebus Holdings, Inc. Share
Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.
